Literature DB >> 15324805

Cdc25 phosphatases and cancer.

K Kristjánsdóttir1, J Rudolph.   

Abstract

The Cdc25 phosphatases function as key regulators of the cell cycle during normal eukaryotic cell division and as mediators of the checkpoint response in cells with DNA damage. The role of Cdc25s in cancer has become increasingly evident in recent years. More than 20 studies of patient samples from diverse cancers show significant overexpression of Cdc25 with frequent correlation to clinical outcome. Recent screening and design efforts have yielded novel classes of inhibitors that show specificity for the Cdc25s over other phosphatases and cause cell cycle arrest in vivo. Herein we provide a single source for those interested in the cellular functions of Cdc25 in cell cycle progression, its role in the progress of cancer and survival of cancer patients, and recent efforts in the design of specific inhibitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15324805     DOI: 10.1016/j.chembiol.2004.07.007

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  95 in total

1.  The Protein Phosphatases and Protein Kinases of Arabidopsis thaliana.

Authors:  Huachun Wang; David Chevalier; Clayton Larue; Sung Ki Cho; John C Walker
Journal:  Arabidopsis Book       Date:  2007-02-20

2.  A novel mechanism of indole-3-carbinol effects on breast carcinogenesis involves induction of Cdc25A degradation.

Authors:  Yongsheng Wu; Xiaoling Feng; Yucui Jin; Zhaojia Wu; William Hankey; Carolyn Paisie; Lei Li; Fengjuan Liu; Sanford H Barsky; Weiwei Zhang; Ramesh Ganju; Xianghong Zou
Journal:  Cancer Prev Res (Phila)       Date:  2010-06-29

Review 3.  Role of protein tyrosine phosphatases in cancer.

Authors:  Tasneem Motiwala; Samson T Jacob
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

4.  Protein tyrosine and serine-threonine phosphatases in the sea urchin, Strongylocentrotus purpuratus: identification and potential functions.

Authors:  C A Byrum; K D Walton; A J Robertson; S Carbonneau; R T Thomason; J A Coffman; D R McClay
Journal:  Dev Biol       Date:  2006-08-25       Impact factor: 3.582

Review 5.  Therapeutic opportunities to control tumor cell cycles.

Authors:  Marcos Malumbres
Journal:  Clin Transl Oncol       Date:  2006-06       Impact factor: 3.405

6.  Inappropriate activation of cyclin-dependent kinases by the phosphatase Cdc25b results in premature mitotic entry and triggers a p53-dependent checkpoint.

Authors:  Shohreh Varmeh; James J Manfredi
Journal:  J Biol Chem       Date:  2009-01-09       Impact factor: 5.157

7.  Effects of let-7c on the proliferation of ovarian carcinoma cells by targeted regulation of CDC25a gene expression.

Authors:  Wei Zhang; Qingru Zeng; Zhenying Ban; Jing Cao; Tianjiao Chu; Dongmei Lei; Chi Liu; Wentao Guo; Xianxu Zeng
Journal:  Oncol Lett       Date:  2018-08-20       Impact factor: 2.967

8.  Toward the virtual screening of Cdc25A phosphatase inhibitors with the homology modeled protein structure.

Authors:  Hwangseo Park; Young Ho Jeon
Journal:  J Mol Model       Date:  2008-05-27       Impact factor: 1.810

Review 9.  In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets.

Authors:  Hiroaki Kiyokawa; Dipankar Ray
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

10.  Downregulation of LncRNAH19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3β/Cdc25A signaling pathway.

Authors:  Jun Lv; Ling Ma; Xi-Lin Chen; Xiao-Hui Huang; Qian Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.